NCT04530175View on ClinicalTrials.gov

Modeling of Regional Citrate Anticoagulation With a Dialysate Containing Calcium in Intermittent Hemodialysis (MARC)

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

July 7, 2021

Study Completion Date

July 7, 2021

Conditions
End Stage Renal Disease
Interventions
OTHER

blood sampling

2 blood samples will be taken from the blood circuit 1 hour after the start of the hemodialysis session by the nurse in charge of the patient.

Trial Locations (1)

63000

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT04530175 - Modeling of Regional Citrate Anticoagulation With a Dialysate Containing Calcium in Intermittent Hemodialysis (MARC) | Biotech Hunter | Biotech Hunter